Avalo Therapeutics, Inc.
NASDAQ:AVTX
9.3714 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -31.544 | -41.658 | -84.376 | -63.5 | -16.073 | -40.053 | 11.87 | -16.472 | -10.49 | -16.056 | -13.045 | -10.49 |
| Depreciation & Amortization
| 0.158 | 0.166 | 1.657 | 1.843 | 3.884 | 4.555 | 0.425 | 0.027 | 0.024 | 0.029 | 0.02 | 0.015 |
| Deferred Income Tax
| 0.014 | 0.028 | 0.022 | 0.196 | 0.017 | -0.017 | -0.833 | -0.073 | -1.313 | -1.184 | 0 | 0 |
| Stock Based Compensation
| 3.477 | 7.554 | 8.172 | 6.786 | 2.532 | 2.431 | 1.157 | 1.695 | 0.395 | 1.087 | 0.749 | 0.588 |
| Change In Working Capital
| -9.24 | 4.77 | 2.839 | -4.437 | -2.027 | 8.733 | -0.467 | 0.087 | 0.928 | -0.383 | 0.644 | 0 |
| Accounts Receivables
| 1.783 | 1.06 | 1.117 | -0.678 | 1.658 | -0.223 | -0.247 | -0.132 | 0 | 0 | 0 | 0 |
| Inventory
| 0.02 | 0.018 | -0.035 | 0.018 | 0.533 | -0.311 | -0.203 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.436 | -0.487 | 0.796 | 0.099 | 1.019 | 0.082 | 0.096 | 0.332 | -0.269 | -0.708 | 0.818 | 0 |
| Other Working Capital
| -8.607 | 4.179 | 0.961 | -3.875 | -5.237 | 9.184 | -0.113 | -0.245 | 1.196 | 0.325 | -0.174 | 0 |
| Other Non Cash Items
| 6.455 | 2.389 | 0.794 | 18.573 | -7.468 | 21.222 | 0.366 | 0.162 | 0.294 | 0.989 | 0.147 | 1.186 |
| Operating Cash Flow
| -30.68 | -26.751 | -70.892 | -40.54 | -19.134 | -3.128 | 12.519 | -14.573 | -10.163 | -15.518 | -11.485 | -9.288 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.158 | -0.095 | -0.113 | -0.063 | -0.262 | -0.564 | -0.023 | -0.035 | -0.02 | -0.02 | -0.029 | -0.012 |
| Acquisitions Net
| 0.025 | 0 | 0 | 11.195 | 3.958 | 1.43 | -18.889 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | -11,194,917 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 12,836,736 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.158 | 0 | 0 | -1,641,819 | -4.139 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.133 | -0.095 | -0.113 | 11.132 | -0.443 | 0.865 | -18.912 | -0.035 | -0.02 | -0.02 | -0.029 | -0.012 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -21.244 | -14.806 | -32.9 | 0 | -0.256 | 0 | -2.374 | -3.314 | -1.812 | -7.39 | 0 | 0 |
| Common Stock Issued
| 46.286 | 0.107 | 73.862 | 44.452 | 12.685 | 3.857 | 1.693 | 2.003 | 23.685 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0.067 | -14.806 | 0.366 | -0.094 | -0.034 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 46.286 | 0.107 | 73.862 | 0.426 | 1.246 | 6.547 | 4.418 | -0.115 | -2.268 | 23.859 | 5.416 | 17.709 |
| Financing Cash Flow
| 25.042 | -14.699 | 106.762 | 44.785 | 12.559 | 10.404 | 3.737 | -1.426 | 19.603 | 23.859 | 5.416 | 17.709 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -5.771 | -41.545 | 35.757 | 15.377 | -7.018 | 8.141 | -2.656 | -16.034 | 9.42 | 8.321 | -6.098 | 8.408 |
| Cash At End Of Period
| 7.416 | 13.318 | 54.863 | 19.106 | 3.729 | 10.747 | 2.472 | 5.128 | 21.162 | 11.742 | 3.421 | 9.52 |